OMER Omeros Corp

Price (delayed)

$9.79

Market cap

$708.55M

P/E Ratio

7.53

Dividend/share

N/A

EPS

$1.3

Enterprise value

$1.02B

?
Relative Growth: Rel. Growth: 27
Relative Strength: Rel. Strength: 89
Relative Valuation: Rel. Valuation: 84
Relative Profitability: Rel. Profitability: 53

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous ...

Highlights
The net income has soared by 156% YoY
The EPS has surged by 149% year-on-year

Key stats

What are the main financial stats of OMER

OMER stock price

How has the Omeros stock price performed over time
Intraday
-4.49%
1 week
-11.32%
1 month
-33.72%
1 year
196.67%
YTD
-43%
QTD
-7.29%

Financial performance

How have Omeros's revenue and profit performed over time
Revenue
$9.89M
Gross profit
$9.31M
Operating income
-$105.25M
Net income
$86.17M
Gross margin
94.1%
Net margin
871%
The net income has soared by 156% YoY
Omeros's operating income has increased by 35% YoY and by 14% from the previous quarter

Price vs fundamentals

How does OMER's price correlate with its fundamentals

Growth

What is Omeros's growth rate over time

Valuation

What is Omeros stock price valuation
P/E
7.53
P/B
N/A
P/S
71.17
EV/EBIT
11.36
EV/EBITDA
11.25
EV/Sales
102.83
The EPS has surged by 149% year-on-year
OMER's equity has surged by 70% year-on-year and by 48% since the previous quarter

Efficiency

How efficient is Omeros business performance
Omeros's ROIC has soared by 184% YoY
The ROA has soared by 167% YoY

Dividends

What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OMER.

Financial health

How did Omeros financials performed over time
The total assets is 18% less than the total liabilities
The current ratio has soared by 161% YoY and by 10% from the previous quarter
The total assets has grown by 22% YoY but it has contracted by 12% from the previous quarter
Omeros's debt to equity has plunged by 153% YoY and by 46% from the previous quarter
OMER's equity has surged by 70% year-on-year and by 48% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.